Clinical Trial Update: Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating apatinib in combination with temozolomide for uncontrolled or recurrent high-grade gliomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Apatinib (apatinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: WuHui | Conditions: High-grade Gliomas | Phase 2 | Status: UNKNOWN